Approval · Notice of Compliance 33459 · 2024
TECARTUS: Notice of Compliance 33459
Issued June 17, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33459
- Date
- June 17, 2024
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TECARTUS | Not yet assigned | — |
Medicinal ingredients
- BREXUCABTAGENE AUTOLEUCEL 2,000,000 CELLS per BAG
- BREXUCABTAGENE AUTOLEUCEL 100,000,000 CELLS per BAG